CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Lee's Pharmaceutical Holdings Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Lee's Pharmaceutical Holdings Ltd
Unit 110-111, Bio-Inf. Centre,
No.2 Science Park West Avenue,
Phone: +852 23141282p:+852 23141282 Hong Kong Ticker: 950950

Business Summary
Lee's Pharmaceutical Holdings Ltd is an investment holding company principally engaged in the development, manufacturing, marketing and sales of pharmaceutical products. The Company operates its business through two segments. The Imported Products segment is engaged in the sale of imported products. Its imported products include Keyan injection, Fipril oral solution and others. The Proprietary Products segment is engaged in the manufacture and sale of self-developed products. Its R&D products include Resilicon Tablets, ADASUVE Inhalation Powder and others. The Company's medicines cover the fields of cardiovascular and infectious diseases, dermatology, oncology, gynecology and ophthalmology. The Company mainly operates its business in mainland China, Hong Kong and Taiwan.
(Source: ARS)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
6/30/202312/31/2022Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Executive Chairman of the Board Siu FongLee 65
Managing Director, Chief Marketing and Sales Officer, Executive Director WaneeLeelalertsuphakun 68 9/1/2003 9/1/2003
Deputy Managing Director of Zhaoke Pharmaceutical ChengpingZhong 53
12 additional Officers and Directors records available in full report.

Business Names
Business Name
0950
950
China Oncology Focus Limited
L1PA
Lee's Pharmaceutical Holdings Ltd.
Lee’s Pharmaceutical International Limited

General Information
Number of Employees: 1,060 (As of 6/30/2023)
Outstanding Shares: 588,835,343 (As of 6/30/2023)
Stock Exchange: HKG
Fax Number: +852 23141708


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, March 28, 2024